Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Abeona Therapeutics Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 37.06m or 1,058.77% of revenues. In addition the company used 37.01m for operations while cash from investing totalled 208.00k.
Cash flow per share | -1.57 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.76 |
---|---|
Tangible book value per share | 1.76 |
More ▼
Balance sheet in USDView more
Current ratio | 7.48 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2506 |
---|---|
Total debt/total capital | 0.2004 |
More ▼